Related Experiment Video
Updated: Jun 16, 2026
07:02
Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
Published on: May 11, 2018
RNA-targeted splice-correction therapy for neuromuscular disease
Matthew J A Wood1, Michael J Gait, Haifang Yin
1Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford OX1 3QX, UK. matthew.wood@dpag.ox.ac.uk
Brain : a Journal of Neurology
|February 13, 2010
Summary
Splice-modulation therapy using antisense oligonucleotides shows promise for Duchenne muscular dystrophy by restoring dystrophin. This exon skipping approach is advancing towards systemic delivery for broader therapeutic impact.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Duchenne muscular dystrophy (DMD) is a severe childhood genetic disorder affecting 1 in 3500 boys.
- Mutations in the DMD gene cause dystrophin absence, leading to progressive muscle weakness, heart failure, and premature death.
- Current treatments lack a cure, necessitating novel therapeutic strategies.
Purpose of the Study:
- To investigate splice-modulation therapy as a potential treatment for Duchenne muscular dystrophy.
- To evaluate the efficacy of antisense oligonucleotides in restoring dystrophin expression.
- To explore the application of splice-correction methods for related neuromuscular diseases.
Main Methods:
- Utilizing antisense oligonucleotides to modulate pre-messenger RNA splicing in DMD.
- Engineering molecular manipulation of splicing to correct genetic defects.
- Conducting clinical trials for safety and efficacy assessment of direct antisense oligonucleotide injections.
Main Results:
- Splice-modulation therapy demonstrated promising safety and efficacy in recent clinical trials.
- Exon skipping successfully restored functional dystrophin protein production in affected cells.
- Progress has been made in understanding systemic delivery and application to other genetic disorders.
Conclusions:
- Splice-modulation therapy represents a promising novel treatment for Duchenne muscular dystrophy.
- Antisense oligonucleotide-based exon skipping offers a pathway to restore dystrophin.
- Further research is needed for systemic delivery and application to related neuromuscular conditions like spinal muscular atrophy and myotonic dystrophy.
Related Concept Videos
02:18Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
02:18Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
01:32RNA Splicing
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
01:32RNA Splicing
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...